C. Brownscheidle

发表

Magnetic resonance studies of intramuscular interferon β–1a for relapsing multiple sclerosis

Jeanelle Sheeder, C. Granger, R. Herndon, 1998 .

Intramuscular interferon beta‐1a for disease progression in relapsing multiple sclerosis

C. Granger, R. Herndon, R. Kinkel, 1996, Annals of neurology.

A longitudinal study of brain atrophy in relapsing multiple sclerosis

R. Herndon, R. Kinkel, J. Fischer, 1999, Neurology.

A profile of multiple sclerosis: The New York State Multiple Sclerosis Consortium

L. Jacobs, J. Herbert, L. Krupp, 1999, Multiple sclerosis.

Flow Cytometric Analysis of In Vitro Proinflammatory Cytokine Secretion in Peripheral Blood from Multiple Sclerosis Patients

Murali Ramanathan, Lawrence Jacobs, M. Ramanathan, 1999, Journal of Clinical Immunology.

Multiple sclerosis characteristics in A frican A merican patients in the New York State Multiple Sclerosis C onsortium

C. Granger, R. Bakshi, F. Munschauer, 2003, Multiple sclerosis.

In vivo gene expression revealed by cDNA arrays: the pattern in relapsing–remitting multiple sclerosis patients compared with normal subjects

M. Ramanathan, Colleen M. Miller, L. Jacobs, 2001, Journal of Neuroimmunology.

Ultrastructure of the harderian gland in male albino rats

C. Brownscheidle, R. Niewenhuis, 1978, The Anatomical record.

Impact of interferon beta-1a on neurologic disability in relapsing multiple sclerosis. 1997.

R. Kinkel, J. Fischer, R. Rudick, 1997, Neurology.

The effects of maternal diabetes on fetal maturation and neonatal health.

C. Brownscheidle, V. Wootten, M. Mathieu, 1983, Metabolism: clinical and experimental.

Absent or Delayed Preovulatory Luteinizing Hormone Surge in Experimental Diabetes Mellitus

C. Brownscheidle, S. Katayama, K. Shimaoka, 1984, Diabetes.

Sex differences in in vitro pro-inflammatory cytokine production from peripheral blood of multiple sclerosis patients

M. Ramanathan, L. Jacobs, B. Weinstock-Guttman, 2003, Journal of the Neurological Sciences.

Cerebrospinal fluid abnormalities in a phase III trial of Avonex (IFNbeta-1a) for relapsing multiple sclerosis. The Multiple Sclerosis Collaborative Research Group.

C. Granger, R. Kinkel, J. Fischer, 1999, Journal of neuroimmunology.

Orally administered liposome-entrapped insulin in diabetic animals. A critical assessment.

M. Sinha, M. Sperling, C. Brownscheidle, 1982, Hormone research.

Sensory Abnormalities in MS

R. Bakshi, Colleen M. Miller, L. Jacobs, 2004 .

Pattern reversal visual evoked potentials as a measure of visual pathway pathology in multiple sclerosis

R. Rudick, E. Fisher, B. Weinstock-Guttman, 2003, Multiple sclerosis.

Appropriate Use of Interferon Beta-1a in Multiple Sclerosis

L. Jacobs, C. Brownscheidle, 1999, BioDrugs.

Intramuscular interferon beta-1a therapy initiated during a first demyelinating event in multiple sclerosis. CHAMPS Study Group.

J H Simon, R W Beck, R. Beck, 2000, The New England journal of medicine.

Detection of cytochrome P450 and other drug-metabolizing enzyme mRNAs in peripheral blood mononuclear cells using DNA arrays.

M. Ramanathan, B. Weinstock-Guttman, C. Brownscheidle, 2000, Drug metabolism and disposition: the biological fate of chemicals.

Localization of aldose reductase and sorbitol dehydrogenase in the nervous system of normal and diabetic rats

C. Brownscheidle, P. A. Tornheim, S. Orosz, 1981, Acta diabetologia latina.

The uniform data system for medical rehabilitation (UDSmr) and functional health assessment

C. Granger, P. Niewczyk, C. Brownscheidle, 2012 .

A case study of a patient with MS followed for 15 years using patient-reported outcome measures

C. Granger, P. Niewczyk, C. Brownscheidle, 2012 .

Outcome Measurement in Medical Rehabilitation

C. Granger, C V Granger, C. Brownscheidle, 1995, International Journal of Technology Assessment in Health Care.

Comparing the ability of various compositive outcomes to discriminate treatment effects in MS clinical trials

J. Simon, R. Priore, L. Jacobs, 1998, Multiple sclerosis.

Correlation of clinical, magnetic resonance imaging, and cerebrospinal fluid findings in optic neuritis

R. Priore, Colleen M. Miller, L. Jacobs, 1997, Annals of neurology.

Impact of interferon beta-1a on neurologic disability in relapsing multiple sclerosis

R. P. Kinkel, D. L. Cookfair, R. Herndon, 1997, Neurology.

Cerebrospinal fluid abnormalities in a phase III trial of Avonex® (IFNβ-1a) for relapsing multiple sclerosis 1 Studies supported by the National Multiple Sclerosis Society (grants RG2019, RG2827); the NINDS (NS26321); and Biogen Inc. 1

C. Granger, R. Herndon, R. Kinkel, 1999, Journal of Neuroimmunology.

Magnetic resonance studies of intramuscular interferon beta-1a for relapsing multiple sclerosis. The Multiple Sclerosis Collaborative Research Group.

J H Simon, A L Scherzinger, C. Granger, 1998, Annals of neurology.

Predictors of short-term disease activity following a first clinical demyelinating event: analysis of the CHAMPS placebo groupy

Jeffrey A. Cohen, S. Cole, D. Arnold, 2002, Multiple sclerosis.

Are quantitative functional measures more sensitive to worsening MS than traditional measures?

L. Jacobs, L. Krupp, A. Miller, 2000, Neurology.

Diabetes in pregnancy: a preliminary study of the pancreas, placenta and malformations in the BB Wistar rat.

C. Brownscheidle, D. L. Davis, 1981, Placenta. Supplement.

The Estrous Cycle of an African Bongo: Breeding Behavior and Cytology of Vaginal Smears

C. Brownscheidle, B. Dresser, P. Russell, 1979 .

Use of the FIM™ Instrument in a Trial of Intramuscular Interferon &bgr;-1a for Disease Progression in Relapsing-Remitting Multiple Sclerosis

C. Granger, K. Wende, C. Brownscheidle, 2003, American journal of physical medicine & rehabilitation.

The ultrastructure of the placenta in maternal diabetes mellitus

D. Witte, C. Brownscheidle, 1980 .